A detailed history of Bartlett & Co. Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 71,745 shares of NVO stock, worth $8.03 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
71,745
Previous 73,965 3.0%
Holding current value
$8.03 Million
Previous $10.6 Billion 19.09%
% of portfolio
0.12%
Previous 0.16%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$119.07 - $145.42 $264,335 - $322,832
-2,220 Reduced 3.0%
71,745 $8.54 Billion
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $3.05 Million - $4.07 Million
-29,916 Reduced 28.8%
73,965 $9.57 Billion
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $53,282 - $64,008
607 Added 0.59%
103,881 $10.7 Billion
Q3 2023

Feb 14, 2024

BUY
$90.94 - $199.54 $4.7 Million - $10.3 Million
51,637 Added 100.0%
103,274 $9.39 Billion
Q4 2022

Feb 14, 2024

SELL
$102.55 - $135.33 $159,670 - $210,708
-1,557 Reduced 2.93%
51,637 $6.99 Billion
Q1 2022

Feb 14, 2024

SELL
$93.1 - $112.54 $116,840 - $141,237
-1,255 Reduced 2.3%
53,194 $5.96 Billion
Q3 2021

Feb 13, 2024

SELL
$84.42 - $106.62 $2,026 - $2,558
-24 Reduced 0.04%
54,449 $5.23 Billion
Q1 2021

Feb 13, 2024

SELL
$67.06 - $75.82 $90,531 - $102,356
-1,350 Reduced 2.42%
54,473 $3.68 Billion
Q4 2020

Feb 13, 2024

SELL
$63.89 - $73.8 $55,200 - $63,763
-864 Reduced 1.52%
55,823 $3.9 Billion
Q3 2020

Feb 13, 2024

SELL
$63.69 - $70.22 $47,767 - $52,665
-750 Reduced 1.31%
56,687 $3.94 Billion
Q1 2020

Feb 13, 2024

SELL
$49.46 - $64.78 $135,025 - $176,849
-2,730 Reduced 4.54%
57,437 $3.5 Billion
Q4 2019

Feb 13, 2024

SELL
$49.86 - $58.26 $17,949 - $20,973
-360 Reduced 0.59%
60,167 $3.48 Billion
Q3 2019

Feb 13, 2024

BUY
$47.54 - $53.43 $31,709 - $35,637
667 Added 1.11%
60,527 $3.13 Billion
Q2 2019

Feb 13, 2024

SELL
$46.79 - $52.47 $18,248 - $20,463
-390 Reduced 0.65%
59,860 $3.06 Billion
Q1 2019

Feb 13, 2024

SELL
$46.36 - $52.63 $92,720 - $105,260
-2,000 Reduced 3.21%
60,250 $3.2 Billion
Q4 2018

Feb 13, 2024

SELL
$41.54 - $47.25 $3,738 - $4,252
-90 Reduced 0.14%
62,250 $2.87 Billion
Q2 2018

Feb 13, 2024

SELL
$44.29 - $50.42 $17,937 - $20,420
-405 Reduced 0.65%
62,340 $2.88 Billion
Q1 2018

Feb 13, 2024

BUY
$48.49 - $58.14 $3.04 Million - $3.65 Million
62,745 New
62,745 $3.14 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.